Home › Studies › PRJEB22515
PRJEB22515 ERP104196

Diet intervention study of gut microbial metabolites in adults

Identifying_gut_microbial_metabolites_and_the_bacteria_responsible_for_their_formation

126 samples from healthy adults in a dietary intervention study examining how macronutrients and plant phytochemicals are metabolized by gut bacteria into microbial metabolites. machine-written summary

126 samples · 126 runs · Adult · 2018 · 20.6 Mbp / sample

Sources
✓Sequence archive 126✓Abstract / description 126–Full text–Supplementary tables–External resources–User contribution–Human verified

Checked this project's papers and archive records yourself? Mark it human-verified.

what each source gave
✓ Sequence archive126 sample values (subject id)
✓ Abstract / description126 sample values (health condition)
– Full textno open-access full text linked
– Supplementary tablesno supplementary tables available (or none open access)
– External resourcesnot covered by the external resources we ingest
– User contributionnothing uploaded yet
– Human verifiednot yet checked by a person · I checked this project — verify it
Interventions

intervention — arms not resolved

Controlled / prescribed diet or feeding regimen design crossover · population healthy_control · Human dietary intervention varying macronutrients and phytochemicals

“human dietary intervention study addresses the combined effects” — bioproject.description (study level; per-sample arms are in the intervention column below)

Samples at a glance
Age
adult126
Condition
healthy_control126
Body site
primary126
Sequencing depth per sample · this project all projects
all projects, 0–0.03 Gbp: 25,080 samples (4 %)this project, 0–0.03 Gbp: 124 samplesall projects, 0.03–0.1 Gbp: 17,066 samples (3 %)this project, 0.03–0.1 Gbp: 1 samplesall projects, 0.1–0.3 Gbp: 29,179 samples (5 %)this project, 0.1–0.3 Gbp: 1 samplesall projects, 0.3–1 Gbp: 47,044 samples (8 %)all projects, 1–3 Gbp: 124,983 samples (22 %)all projects, 3–10 Gbp: 253,728 samples (44 %)all projects, 10–30 Gbp: 72,533 samples (13 %)all projects, 30–100 Gbp: 3,024 samples (1 %)all projects, 100–300 Gbp: 106 samples (0 %)all projects, ≥ 300 Gbp: 9 samples (0 %)project median 0.02 Gbp per sample0130Gbp
Community composition

No Sandpiper profile for this project's samples yet.

Field coverage
fieldsamplescoverageR1R2R3R4
age_category126 100%
country0 0%
health_condition126 100%126
subject_id126 100%126
Details
Archive description

The gut microbiota plays a vital role in inflammation and in the development of many diseases including diabetes, cardiovascular disease and cancer. Links between host diet and the gut microbiota are known to influence disease risk. However, relatively little is known about the functionality and role of even the most dominant commensal organisms within the human host. Many of the products of microbial metabolism of dietary compounds remain uncharacterised and consequently, their mechanisms of action unknown. There is a large amount of literature suggesting that plant phytochemicals have anti-cancer properties. Data regarding the metabolism and bioavailability of phytochemicals is lacking, particularly with reference to their release and transformation by the activities of the gut microbiota, and absorption from the colon. Additionally, the relationship between the main macronutrients (carbohydrate and protein) and non-nutrient phytochemicals is poorly understood. It is likely that it is a combination of these dietary factors that modulates both the gut bacteria and the overall metabolite profile, both in the gut and in the systemic circulation. This human dietary intervention study addresses the combined effects of the macro- and non-nutrient components of the diet, along with the gut microbial composition on the production of microbial metabolites. Our hypothesis is that phytochemicals bound to plant polymers reach the colon largely intact and are metabolised and released by the gut microbiota where they can exert a direct anti-inflammatory action on the gut mucosa. This will suppress low-level chronic systemic inflammation, which is a hallmark of aging and certain diseased states including obesity, cardiovascular disease and cancer. Furthermore, the source and type of polymer may improve or exacerbate the effect by modulating the gut bacteria and/or provision of beneficial or detrimental by-products This data is part of a pre-publication release. For information on the proper use of pre-publication data shared by the Wellcome Trust Sanger Institute (including details of any publication moratoria), please see http://www.sanger.ac.uk/datasharing/

How this project entered the registry

Classified as human gut / stool shotgun DNA metagenome of adult by sonnet_x2 with confidence 0.62. Assay shotgun_dna.

  • host run.scientific_name · “human metagenome”
  • body site study.title · “gut_microbial_metabolites”
  • life stage study.description · “This human dietary intervention study”
Evidence examples (one per field × route)
samplefieldvaluerouteconf.sourcequote
SAMEA104288853health_conditionhealthy_controlR40.50study.descriptionhuman dietary intervention study
SAMEA104288853subject_id4947STDY7084138R10.85sample.attr.subject_id4947STDY7084138
Sequencing

126 runs over 126 samples · mean 21.1 Mbp per run (median 20.6 Mbp, total 2.66 Gbp; 126 runs with a base count) · layout PAIRED 126 · platform ILLUMINA 126 · models Illumina MiSeq (126) · 0% of runs with a Sandpiper profile · first public 2018-10-02

Authors (0)

No author record.

Downloads

PRJEB22515.csv.gz (3.4 KB) · parquet (74.0 KB) — all 126 samples, every field with route and confidence · PRJEB22515_determinations.csv.gz (2.4 KB) — 252 evidence rows

Samples (126 · every field this project has values for · hover a cell for its source)
Loading the sample table…